IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $432 | +4.1% | 44,896 | +15.2% | 0.03% | 0.0% |
Q2 2023 | $415 | +11.6% | 38,989 | +10.4% | 0.03% | +22.2% |
Q1 2023 | $372 | -15.8% | 35,319 | -1.0% | 0.03% | -27.0% |
Q4 2022 | $442 | -99.9% | 35,685 | -17.6% | 0.04% | -11.9% |
Q3 2022 | $449,000 | +4.4% | 43,304 | +16.2% | 0.04% | +7.7% |
Q2 2022 | $430,000 | +48.8% | 37,265 | +62.1% | 0.04% | +333.3% |
Q1 2022 | $289,000 | +58.8% | 22,986 | +47.3% | 0.01% | +50.0% |
Q4 2021 | $182,000 | -1.6% | 15,602 | +10.4% | 0.01% | -25.0% |
Q3 2021 | $185,000 | +35.0% | 14,130 | +15.3% | 0.01% | -27.3% |
Q1 2021 | $137,000 | – | 12,254 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |